{"transactions":[{"id":722615,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T23:31:08.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":52781,"price":2.49,"value":131424.69,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on June 29, 2027 while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":227214,"derivative":{"exercise_price":2.49,"exercise_date":"2027-06-29","expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":52781},"source":{"system":"sec-edgar","filing":"0001493152-26-031377","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226031377/ownership.xml","form_type":"4"}},{"id":814266,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2026-04-06T22:33:10.000Z","date":"2026-04-06","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.03,"value":50750.0,"ownership":{"direct":true},"balance_after":160679,"source":{"system":"sec-edgar","filing":"0001493152-26-015357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226015357/ownership.xml","form_type":"4"}},{"id":819026,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2026-04-02T21:05:58.000Z","date":"2026-04-02","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.02,"value":50500.0,"ownership":{"direct":true},"balance_after":135679,"source":{"system":"sec-edgar","filing":"0001493152-26-014959","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226014959/ownership.xml","form_type":"4"}},{"id":950292,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T20:50:00.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":8,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on January 2, 2027, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":182668,"derivative":{"exercise_price":8,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-000361","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226000361/ownership.xml","form_type":"4"}},{"id":961862,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T22:09:42.000Z","date":"2025-12-18","kind":"grant","planned":false,"acquired":true,"shares":8629,"price":4.2,"value":36241.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 18, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":157668,"derivative":{"exercise_price":4.2,"exercise_date":"2026-12-18","expiration_date":"2035-12-18","underlying":"Common Stock","underlying_shares":8629},"source":{"system":"sec-edgar","filing":"0001493152-25-028597","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315225028597/ownership.xml","form_type":"4"}},{"id":1318336,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T00:47:51.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":10320,"price":4.8,"value":49536.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 23, 2025, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":132688,"derivative":{"exercise_price":4.8,"exercise_date":"2025-12-23","expiration_date":"2034-12-23","underlying":"Common Stock","underlying_shares":10320},"source":{"system":"sec-edgar","filing":"0001493152-25-000123","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315225000123/ownership.xml","form_type":"4/A","original_submission_date":"2024-12-30"}},{"id":1318335,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T00:46:47.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":16371,"price":4.86,"value":79563.06,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on January 2, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":149039,"derivative":{"exercise_price":4.86,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":16371},"source":{"system":"sec-edgar","filing":"0001493152-25-000121","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315225000121/ownership.xml","form_type":"4"}},{"id":1320303,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-31T01:04:57.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":26691,"price":4.8,"value":128116.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 23, 2025, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":149039,"derivative":{"exercise_price":4.8,"exercise_date":"2025-12-23","expiration_date":"2034-12-23","underlying":"Common Stock","underlying_shares":26691},"source":{"system":"sec-edgar","filing":"0001493152-24-052577","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224052577/ownership.xml","form_type":"4"}},{"id":1580438,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-03-12T21:53:28.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":4893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units subject to vesting whereby 1/3 of the shares subject to the award will vest on the one-year anniversary of March 8, 2025, while the remaining 2/3 of the shares subject to the award will vest semi-annually on a prorated basis over the following two years."}],"balance_after":112311,"source":{"system":"sec-edgar","filing":"0001493152-24-009707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224009707/ownership.xml","form_type":"4"}},{"id":1877710,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-05-25T19:10:46.000Z","date":"2023-05-25","kind":"purchase","planned":false,"acquired":true,"shares":8706,"price":5.03,"value":43791.18,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Prior to May 11, 2023, Mr. Patel held 1,678,090 shares of common stock. On May 11, 2023, the Company effected a reverse stock split at a ratio of 1-for17, which resulted in a change in Mr. Patel's shares of common stock to 98,712 as of May 11, 2023."}],"balance_after":107418,"source":{"system":"sec-edgar","filing":"0001493152-23-019050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223019050/ownership.xml","form_type":"4"}},{"id":1938990,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-03-24T21:28:03.000Z","date":"2023-03-24","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":0.32,"value":48000.0,"ownership":{"direct":true},"balance_after":1678090,"source":{"system":"sec-edgar","filing":"0001493152-23-008943","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223008943/ownership.xml","form_type":"4"}},{"id":1946094,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-03-17T20:31:41.000Z","date":"2023-03-17","kind":"purchase","acquired":true,"shares":50000,"price":0.33,"value":16500.0,"ownership":{"direct":true},"balance_after":1528090,"source":{"system":"sec-edgar","filing":"0001493152-23-008087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223008087/ownership.xml","form_type":"4"}},{"id":2065970,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T17:06:47.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":300000,"price":0.41,"value":123000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 3,2024, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":2542395,"derivative":{"exercise_price":0.41,"exercise_date":"2024-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-23-000274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223000274/ownership.xml","form_type":"4"}},{"id":2077420,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-23T00:20:50.000Z","date":"2022-12-22","kind":"grant","acquired":true,"shares":112500,"price":0.41,"value":46125.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 22, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years."}],"balance_after":2242395,"derivative":{"exercise_price":0.41,"exercise_date":"2023-12-22","expiration_date":"2032-12-22","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001493152-22-036373","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222036373/ownership.xml","form_type":"4"}},{"id":2117506,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-11-14T20:58:33.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":75000,"price":0.39,"value":29250.0,"ownership":{"direct":true},"balance_after":1478090,"source":{"system":"sec-edgar","filing":"0001493152-22-031971","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222031971/ownership.xml","form_type":"4"}},{"id":2150407,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-09-27T22:53:05.000Z","date":"2022-09-27","kind":"purchase","acquired":true,"shares":100000,"price":0.41,"value":41000.0,"ownership":{"direct":true},"balance_after":1403090,"source":{"system":"sec-edgar","filing":"0001493152-22-026945","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222026945/ownership.xml","form_type":"4"}},{"id":2269860,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-05-16T22:44:41.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":50000,"price":0.7699,"value":38495.0,"ownership":{"direct":true},"balance_after":1303090,"source":{"system":"sec-edgar","filing":"0001493152-22-014014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222014014/ownership.xml","form_type":"4"}},{"id":2453675,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-03T22:33:10.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":287500,"price":1.09,"value":313375.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 3, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":287500,"derivative":{"exercise_price":1.09,"exercise_date":"2023-01-03","expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":287500},"source":{"system":"sec-edgar","filing":"0001493152-22-000154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222000154/ownership.xml","form_type":"4"}},{"id":2480223,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-08T21:00:25.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":125000,"price":1.12,"value":140000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":125000,"derivative":{"exercise_price":1.12,"exercise_date":"2022-12-07","expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-21-030818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315221030818/ownership.xml","form_type":"4"}},{"id":2504398,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-11-19T00:23:09.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":25000,"price":1.09,"value":27250.0,"ownership":{"direct":true},"balance_after":1253090,"source":{"system":"sec-edgar","filing":"0001493152-21-029268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315221029268/ownership.xml","form_type":"4"}},{"id":2925027,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T02:02:38.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":275000,"price":1.43,"value":393250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 4, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 4, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."}],"balance_after":275000,"derivative":{"exercise_price":1.43,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001638599-21-000014","document":"doc4_6979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859921000014/doc4_6979.xml","form_type":"4"}},{"id":2929966,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-29T20:27:43.000Z","date":"2020-12-28","kind":"other","acquired":false,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 15, 2020, the issuer granted to the reporting person, under the issuer's stock incentive plan, options to purchase 375,000 shares of the issuer's common stock.  On December 28, 2020, the issuer rescinded and cancelled 275,000 of the options granted, for no consideration."}],"balance_after":100000,"derivative":{"exercise_price":1.37,"exercise_date":"2021-12-15","expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001638599-20-000995","document":"doc4_6974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000995/doc4_6974.xml","form_type":"4"}},{"id":2939429,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T21:06:16.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":45000,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001638599-20-000977","document":"doc4_6960.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000977/doc4_6960.xml","form_type":"4"}},{"id":2939428,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T21:06:16.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":375000,"price":1.37,"value":513750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 15, 2021, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."}],"balance_after":375000,"derivative":{"exercise_price":1.37,"exercise_date":"2021-12-15","expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001638599-20-000977","document":"doc4_6960.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000977/doc4_6960.xml","form_type":"4"}},{"id":2939427,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-17T21:06:16.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":15000,"price":1.35,"value":20250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1228090,"source":{"system":"sec-edgar","filing":"0001638599-20-000977","document":"doc4_6960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000977/doc4_6960.xml","form_type":"4"}},{"id":2939426,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-17T21:06:16.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":1243090,"source":{"system":"sec-edgar","filing":"0001638599-20-000977","document":"doc4_6960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000977/doc4_6960.xml","form_type":"4"}},{"id":2953052,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-08T21:50:55.000Z","date":"2020-12-05","kind":"exercise","acquired":false,"shares":122978,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":122978,"derivative":{"exercise_price":0,"exercise_date":"2020-12-05","expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":122978},"source":{"system":"sec-edgar","filing":"0001638599-20-000949","document":"doc4_6948.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000949/doc4_6948.xml","form_type":"4"}},{"id":2953051,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-08T21:50:55.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."}],"balance_after":145000,"derivative":{"exercise_price":0,"exercise_date":"2020-12-04","expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001638599-20-000949","document":"doc4_6948.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000949/doc4_6948.xml","form_type":"4"}},{"id":2953050,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:55.000Z","date":"2020-12-05","kind":"exercise","acquired":true,"shares":122978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":1198090,"source":{"system":"sec-edgar","filing":"0001638599-20-000949","document":"doc4_6948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000949/doc4_6948.xml","form_type":"4"}},{"id":2953049,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:55.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":43500,"price":1.5663,"value":68134.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of shares sold at a price that ranged from $1.53 - $1.60"}],"balance_after":1075112,"source":{"system":"sec-edgar","filing":"0001638599-20-000949","document":"doc4_6948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000949/doc4_6948.xml","form_type":"4"}},{"id":2953048,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:55.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":1118612,"source":{"system":"sec-edgar","filing":"0001638599-20-000949","document":"doc4_6948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000949/doc4_6948.xml","form_type":"4"}},{"id":3299885,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-28T21:26:34.000Z","date":"2020-01-28","kind":"grant","acquired":true,"shares":300000,"price":0.458,"value":137400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 28, 2021, while the remaining 2/3 of the shares subject to the award vest monthly on a prorata basis over the following two years."}],"balance_after":300000,"derivative":{"exercise_price":0.458,"exercise_date":"2021-01-28","expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001638599-20-000105","document":"doc4_6489.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000105/doc4_6489.xml","form_type":"4"}},{"id":3326647,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-01-02T16:22:12.000Z","date":"2019-12-31","kind":"purchase","acquired":true,"shares":40000,"price":0.3835,"value":15340.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the average price of shares purchased at prices that ranged from $0.3821-$0.385."}],"balance_after":973612,"source":{"system":"sec-edgar","filing":"0001638599-20-000002","document":"doc4_6445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000002/doc4_6445.xml","form_type":"4"}},{"id":3346305,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-10T18:00:48.000Z","date":"2019-12-10","kind":"purchase","acquired":true,"shares":25000,"price":0.399,"value":9975.0,"ownership":{"direct":true},"balance_after":933612,"source":{"system":"sec-edgar","filing":"0001638599-19-001020","document":"doc4_6390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919001020/doc4_6390.xml","form_type":"4"}},{"id":3349366,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Unit","published_at":"2019-12-06T15:42:06.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":122978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit"}],"balance_after":122978,"derivative":{"exercise_price":0,"exercise_date":"2020-12-05","expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":122978},"source":{"system":"sec-edgar","filing":"0001638599-19-001010","document":"doc4_6381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919001010/doc4_6381.xml","form_type":"4"}},{"id":3349365,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Unit","published_at":"2019-12-06T15:42:06.000Z","date":"2019-12-04","kind":"exercise","acquired":false,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":145000,"derivative":{"exercise_price":0,"exercise_date":"2019-12-04","expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001638599-19-001010","document":"doc4_6381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919001010/doc4_6381.xml","form_type":"4"}},{"id":3349364,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-12-06T15:42:06.000Z","date":"2019-12-04","kind":"sale","acquired":false,"shares":43500,"price":0.41,"value":17835.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":908612,"source":{"system":"sec-edgar","filing":"0001638599-19-001010","document":"doc4_6381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919001010/doc4_6381.xml","form_type":"4"}},{"id":3349363,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-12-06T15:42:06.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":952112,"source":{"system":"sec-edgar","filing":"0001638599-19-001010","document":"doc4_6381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919001010/doc4_6381.xml","form_type":"4"}},{"id":3358478,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-26T16:14:16.000Z","date":"2019-11-26","kind":"purchase","acquired":true,"shares":21928,"price":0.428,"value":9385.184,"ownership":{"direct":true},"balance_after":807112,"source":{"system":"sec-edgar","filing":"0001638599-19-000975","document":"doc4_6360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000975/doc4_6360.xml","form_type":"4"}},{"id":3358477,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-26T16:14:16.000Z","date":"2019-11-26","kind":"purchase","acquired":true,"shares":1100,"price":0.427,"value":469.7,"ownership":{"direct":true},"balance_after":785184,"source":{"system":"sec-edgar","filing":"0001638599-19-000975","document":"doc4_6360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000975/doc4_6360.xml","form_type":"4"}},{"id":3358476,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-26T16:14:16.000Z","date":"2019-11-26","kind":"purchase","acquired":true,"shares":700,"price":0.4266,"value":298.62,"ownership":{"direct":true},"balance_after":784084,"source":{"system":"sec-edgar","filing":"0001638599-19-000975","document":"doc4_6360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000975/doc4_6360.xml","form_type":"4"}},{"id":3358475,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-26T16:14:16.000Z","date":"2019-11-26","kind":"purchase","acquired":true,"shares":1272,"price":0.4265,"value":542.508,"ownership":{"direct":true},"balance_after":783384,"source":{"system":"sec-edgar","filing":"0001638599-19-000975","document":"doc4_6360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000975/doc4_6360.xml","form_type":"4"}},{"id":3367811,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-11-18T21:18:59.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":4810,"price":0.4198,"value":2019.238,"ownership":{"direct":true},"balance_after":782112,"source":{"system":"sec-edgar","filing":"0001638599-19-000966","document":"doc4_6352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000966/doc4_6352.xml","form_type":"4"}},{"id":3367810,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-11-18T21:18:59.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":40259,"price":0.4,"value":16103.6,"ownership":{"direct":true},"balance_after":777302,"source":{"system":"sec-edgar","filing":"0001638599-19-000966","document":"doc4_6352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000966/doc4_6352.xml","form_type":"4"}},{"id":3367809,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-11-18T21:18:59.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":4931,"price":0.3999,"value":1971.9069,"ownership":{"direct":true},"balance_after":737043,"source":{"system":"sec-edgar","filing":"0001638599-19-000966","document":"doc4_6352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000966/doc4_6352.xml","form_type":"4"}},{"id":3509904,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-28T14:54:09.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":2500,"price":1.64,"value":4100.0,"ownership":{"direct":true},"balance_after":732112,"source":{"system":"sec-edgar","filing":"0001638599-19-000557","document":"doc4_6127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000557/doc4_6127.xml","form_type":"4"}},{"id":3509903,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-28T14:54:09.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":473,"price":1.6,"value":756.8,"ownership":{"direct":true},"balance_after":729612,"source":{"system":"sec-edgar","filing":"0001638599-19-000557","document":"doc4_6127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000557/doc4_6127.xml","form_type":"4"}},{"id":3509902,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-28T14:54:09.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":2500,"price":1.59,"value":3975.0,"ownership":{"direct":true},"balance_after":729139,"source":{"system":"sec-edgar","filing":"0001638599-19-000557","document":"doc4_6127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000557/doc4_6127.xml","form_type":"4"}},{"id":3509901,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-28T14:54:09.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":4527,"price":1.58,"value":7152.66,"ownership":{"direct":true},"balance_after":726639,"source":{"system":"sec-edgar","filing":"0001638599-19-000557","document":"doc4_6127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000557/doc4_6127.xml","form_type":"4"}},{"id":3740753,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-06T11:01:27.000Z","date":"2018-12-04","kind":"grant","acquired":true,"shares":150000,"price":1.46,"value":219000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 4, 2019, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."}],"balance_after":150000,"derivative":{"exercise_price":1.46,"exercise_date":"2019-12-04","expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001638599-18-001327","document":"doc4_5817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918001327/doc4_5817.xml","form_type":"4"}},{"id":3740752,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted stock unit","published_at":"2018-12-06T11:01:27.000Z","date":"2018-12-04","kind":"grant","acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."}],"balance_after":290000,"derivative":{"exercise_price":0,"exercise_date":"2019-12-04","expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001638599-18-001327","document":"doc4_5817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918001327/doc4_5817.xml","form_type":"4"}},{"id":4116825,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Restricted Stock Unit","published_at":"2018-01-02T23:16:06.000Z","date":"2017-12-29","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":45000,"derivative":{"exercise_price":0,"exercise_date":"2017-12-29","expiration_date":"2027-01-25","underlying":"Common stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001638599-18-000029","document":"doc4_5171.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000029/doc4_5171.xml","form_type":"4"}},{"id":4116824,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common stock","published_at":"2018-01-02T23:16:06.000Z","date":"2017-12-29","kind":"sale","acquired":false,"shares":6000,"price":3.4778,"value":20866.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of shares sold at a price that ranged from $3.43-$3.55."}],"balance_after":722112,"source":{"system":"sec-edgar","filing":"0001638599-18-000029","document":"doc4_5171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000029/doc4_5171.xml","form_type":"4"}},{"id":4116823,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2018-01-02T23:16:06.000Z","date":"2017-12-29","kind":"exercise","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."}],"balance_after":728112,"source":{"system":"sec-edgar","filing":"0001638599-18-000029","document":"doc4_5171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000029/doc4_5171.xml","form_type":"4"}},{"id":4140152,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-06T23:51:12.000Z","date":"2017-12-06","kind":"grant","acquired":true,"shares":150000,"price":3.52,"value":528000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 6, 2018, while the remaining 2/3 of the shares subject to the award have vesting monthly on a prorata basis over the following two years."}],"balance_after":150000,"derivative":{"exercise_price":3.52,"exercise_date":"2018-12-06","expiration_date":"2027-12-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001638599-17-001224","document":"doc4_5125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859917001224/doc4_5125.xml","form_type":"4"}},{"id":4477010,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2017-01-31T02:41:32.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":60000,"derivative":{"exercise_price":0,"exercise_date":"2017-12-31","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001638599-17-000130","document":"doc4_4497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859917000130/doc4_4497.xml","form_type":"4"}},{"id":4528344,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":34422,"kind":"person","name":"Patel Mahesh V.","position":1,"cik":"0001579872","reported_name":"Patel Mahesh V.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-08T15:49:17.000Z","date":"2016-12-07","kind":"grant","acquired":true,"shares":140000,"price":3.61,"value":505400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2017, while the remaining 2/3 of the shares subject to the award vesting monthly on a prorata basis over the following two years."}],"balance_after":140000,"derivative":{"exercise_price":3.61,"exercise_date":"2017-12-07","expiration_date":"2026-12-07","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001638599-16-001675","document":"doc4_4384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859916001675/doc4_4384.xml","form_type":"4"}}]}